Home > Cashflow Statement > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Cash Flow from Financing Activities

    Back to Cashflow Statement
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

SYNCOM FORMULATIONS (INDIA) Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Cash Flow from Financing Activities ₹-68 Cr₹-15 Cr₹35 Cr₹8.29 Cr₹4.67 Cr

What is the latest Cash Flow from Financing Activities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Cash Flow from Financing Activities ratio of SYNCOM FORMULATIONS (INDIA) is ₹-68 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹-68 Cr
Mar2024₹-15 Cr
Mar2023₹35 Cr
Mar2022₹8.29 Cr
Mar2017₹4.67 Cr

How is Cash Flow from Financing Activities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹-68 Cr
Negative
Mar2024 ₹-15 Cr
Negative
Mar2023 ₹35 Cr
321.95
Mar2022 ₹8.29 Cr
77.66
Mar2017 ₹4.67 Cr -

Compare Cash Flow from Financing Activities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,274.6 Cr -5.6% 4.6% -22.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,827.0 Cr -0.5% 1.8% -2% Stock Analytics
DIVIS LABORATORIES ₹163,363.0 Cr -0.3% -1.3% 4% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,193.0 Cr 4.4% 6% 27.7% Stock Analytics
CIPLA ₹109,519.0 Cr 1% -3% -8.7% Stock Analytics
DR REDDYS LABORATORIES ₹105,940.0 Cr 1.1% 8% 3.8% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-5.6%

4.6%

-22.2%

SENSEX

-0.9%

-0.1%

7%


You may also like the below Video Courses